Navigation Links
SectorWatch.biz Issues MarketStats on Agri-Biotech Equities YGYB, GRO, SEED, MON, ADM, and BG
Date:9/9/2008

IRVINE, Calif., Sept. 9 /PRNewswire/ -- SectorWatch.biz announces the availability of MarketStats for agri-biotech equities in the news and driving markets today. MarketStats offers a perspective on the aforementioned equities and the opportunity for investors to respond with articles, blogs and opinions.

Investors can view MarketStats by visiting: http://www.SectorWatch.biz -- a division of FiSpace.net, a dynamic social networking site for investors.

Today's MarketStats for agri-biotech companies include Yongye Biotechnology International, Inc. (OTC Bulletin Board: YGYB) Agria Corporation (Agria) (NYSE: GRO), Origin Agritech Limited (Nasdaq: SEED), Monsanto Company (NYSE: MON), Archer Daniels Midland Company (NYSE: ADM) and Bunge Limited (Bunge) (NYSE: BG).

For a fact sheet by SmallCapVoice.com, visit the following link: http://www.smallcapvoice.com/ygyb/factsheet.html

FiSpace.net is the premiere Internet destination for stock market readers and writers, allowing individuals to post blogs, articles, messages and more in organized sector channels, creating the effective exchange of ideas. By posting content on FiSpace.net individuals can acquire F.A.N.S. (Financial Networked Subscribers) who help increase the author's influence and standing on the site in an unprecedented way.

SectorWatch.biz is powered by Market Pathways, a leader in the representation of Small Cap equities for nearly thirty years. Market Pathways' analyst Brian Kelly holds CRD #2880975. To be featured in our publications please use the number below.

Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results. SectorWatch.biz, FiSpace.net and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience. The subject companies have not always approved the statements made in this report. This report is neither a solicitation to buy nor an offer to sell securities but is for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor, analyst or licensed broker dealer and this report is not investment advice. MP has been paid 1,500 dollars by SmallCapVoice.com for preparation and distribution of this report and other advertising services. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject company.


'/>"/>
SOURCE SectorWatch.biz
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. SectorWatch.biz Issues MarketStats on CVBT, BSX, MDT, CXM and DNA
2. SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT
3. Pharmos Issues Letter to Shareholders
4. MichBio Issues 2007/8 Michigan Life Sciences Directory and Resources Guide
5. HHS Issues First Department-Wide Report on Personalized Health Care
6. CalbaTech Issues Update; Beginning Training for Adult Stem Cell Collections in Atlanta
7. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
8. CCPM Issues Statement on FDAs GIVE Initiative
9. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
10. FDA Issues Approvable Letter for LUVOX(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
11. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest features ... will also be presenting a scientific poster on Disrupting Clinical Trials in The ...
(Date:6/23/2016)... PUNE, India , June 23, 2016 /PRNewswire/ ... culture media market research report to its pharmaceuticals ... company profiles, product details and much more. ... market spread across 151 pages, profiling 15 companies ... now available at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . ...
Breaking Biology Technology:
(Date:6/20/2016)... 2016 Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring announced that ... has secured the final acceptance by all three ... Access Systems (MAS) installed. Furthermore, Securus will have ... installed by October, 2016. MAS distinguishes between legitimate ...
(Date:6/15/2016)... , June 15, 2016 ... market report titled "Gesture Recognition Market by Application Market - Global ... 2016 - 2024". According to the report, the  global ... billion in 2015 and is estimated to grow ... 48.56 billion by 2024.  Increasing application ...
(Date:6/9/2016)... Finland , June 9, 2016 ... National Police deploy Teleste,s video security solution to ensure the ... France during the major tournament ... data communications systems and services, announced today that its video ... Prefecture to back up public safety across the ...
Breaking Biology News(10 mins):